Oncology Acute Myeloid Leukemia Explore

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Current Events

2023 ASCO Annual Meeting
Chicago, June 02, 2023 - June 06, 2023
EHA 2023 Hybrid Congress
Frankfurt, June 08, 2023 - June 11, 2023

Meet Our Experts

PracticeUpdate is guided by a world-renowned Editorial and Advisory Board that represents community practitioners and academic specialists with cross-disciplinary expertise. View all boards

Cardiology

Douglas Zipes MD
Editor in Chief

Clinical Dentistry

Michael Newman DDS, FACD
Editor in Chief

Dermatology

Robert Brodell MD, FAAD
Editor in Chief

Diabetes

Silvio Inzucchi MD
Editor in Chief

Eye Care

Paul Freeman OD, FAAO, FCOVD
Editor in Chief

Eye Care

Myron Yanoff MD
Editor in Chief

Gastroenterology

Gail Hecht MD
Editor in Chief

Neurology

Mark Hallett MD
Editor in Chief

Oncology

Rafael Fonseca MD
Editor in Chief

Primary Care

David Rakel MD, FAAFP
Editor in Chief

Respiratory Medicine

Shyoko Honiden MD, MSc
Editor in Chief

Welcome to PracticeUpdate,

Acute Myeloid Leukemia

Current Events

Editor's Picks

Olaparib Plus Bevacizumab as First-Line Maintenance for Advanced Ovarian Cancer

Association Between Treatment Intensity, Measurable Residual Disease, and Outcomes in Patients With AML

Clinical and Pathologic Correlates and Sensitivity to Lenalidomide Withdrawal in Patients With Lenalidomide-Associated B-ALL

Ex Vivo Venetoclax Sensitivity Testing Predicts Treatment Response in Patients With AML

Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis

Long-Term Overall Survival Outcomes of Maintenance Olaparib in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation

Expert Opinion

Wilms' Tumor Antigen and Multiple Myeloma

ASCO 2021: Abstract Recommendations From Dr. Isabel Cunningham for Hematologic Malignancies

ASH 2020: Abstract Recommendations From Dr. Isabel Cunningham

ASCO: Practice Changers in Palliative Care and Acupuncture

ASCO 2020: Abstract Recommendations From Dr. Isabel Cunningham for Hematologic Malignancies

Journal Scans

Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged AML

Olaparib Plus Bevacizumab as First-Line Maintenance for Advanced Ovarian Cancer

Real-World Outcomes of Older Adults With AML Receiving Frontline Venetoclax-Based Therapy

Association Between Treatment Intensity, Measurable Residual Disease, and Outcomes in Patients With AML

Impact of Gilteritinib vs Salvage Chemotherapy on Patient-Reported Outcomes in Patients With FLT3-Mutated Relapsed/Refractory AML

Surveys

News

Processed Red Meat Intake Linked to Increased Incidence of Blood Cancers

Variants ID Outcomes in Adults With Leukemia in Relapse Prior to Stem Cell Transplant

Survival Lower for Children With Leukemia Living on Texas-Mexico Border

Allogeneic Stem Cell Transplant Feasible for Leukemia in Elderly Patients

2022 ICC Recategorization Facilitates Risk Stratification of Myelodysplastic Syndrome

Oops! We have no items to display.

Meet Our Experts

Recently Updated